BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
Quick Stats
May 13, 202659.5
AI Score
HOLD1.16
Volume Ratio
May 04, 2026
Next Earnings
15
+ve Days (30d)
15
-ve Days (30d)
BMRN Stock Summary
Last updated May 13, 2026
BMRN is currently trading at $53.55, positioned below its 200-day moving average of $56.17, suggesting bearish momentum. The stock has a 52-week range of $50.76 to $66.275.
Technical Analysis: The 50-day moving average stands at $55.67, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 45.684, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.019, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates BMRN at 59.5/100 with a HOLD recommendation.
BMRN (BioMarin Pharmaceuticals Inc) Indicators
Last updated May 13, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 45.684 |
| CMF (20) | -0.019 |
| ROC (10) | -1.217 |
| ADX (14) | 17.227 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.629 |
| AROONOSC (14) | -42.857 |
| WILLAMS %R (14) | -72.575 |
| MFI (14) | 37.38 |
BMRN Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
BMRN Price vs Max Options Open Interest
BMRN Max Change In Options Open Interest
BMRN Options - Sort by Max open Interest (near term)
14th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
BMRN Daily Out of Money Options - Sort by Max open Interest (near term)
14th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
BMRN Daily In the Money Options - Sort by Max open Interest (near term)
14th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
BMRN Most Active Options by Volume(near term)
14th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
BioMarin Pharmaceuticals Inc is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
BMRN Moving Averages Analysis
BMRN (BioMarin Pharmaceuticals Inc) Simple Moving Averages
Moving Averages are last updated May 13, 2026
| Days | MA |
|---|---|
| 10 | 53.85 |
| 20 | 53.97 |
| 30 | 54.6 |
| 50 | 55.67 |
| 100 | 57.27 |
| 200 | 56.17 |
BMRN Fundamental Analysis
| P/E (Forward) | 10.8578 |
| P/E (Trailing) | 37.8273 |
| Market Cap ($) | 10.2 billion |
| Earnings/Share ($) | 1.39 |
| Net Proft Margin (%) | 0.0829 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 4.9171 |
| EPS Estimate Next Year ($) | 6.6533 |
| WallStreet Target Price ($) | 90.625 |
| Most Recent Quarter |